«Health»: Suvaldy achieved impressive results with 90% of patients

Dr. Gamal Esmat, Vice Chairman of the National Committee to Combat Viral Hepatitis, that nearly 90% of the results of the initial tests for patients with C virus, who underwent treatment drug Alsuvaldy, came negative for the virus, confirming that the drug has already achieved impressive results, pointing out that this The results are not final and must for the patient to complete the course of treatment, and after the show the final result.

Ismet said, in a press statement, the normal course of the patient, who gets the triple therapy, Alsuvaldy interferon and Alrebavern 0.3 months of treatment, and for patients with cystic and do not get interferon extends to 6 months.

He pointed out that the amounts Alsuvaldy available in Egypt now sufficient treatment 5 times the patients who received it, denying what is being said about the existence of a deficit in the quantities or the late arrival of the new doses, stressing that it is an organizational purely depends on the ability of the Commission to examine applicants patients for treatment and determine where applicable the treatment protocol, and the exclusion of cases which recorded a non-infected from the database, as well as the completion of the injured for all required tests.

Esmat explained that the Committee had begun to address the ethics committee of scientific research for approval to conduct clinical trials on the Egyptians patients regarding new treatment, Alharvony, to ensure its effectiveness, especially as it received approval from the Food and Drug Administration for the treatment of type I gene, not the fourth is located in Egypt.